JPRN-UMIN000021619已完成未知
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on biomarkers in early diabetic nephropathy in Japanese with type 2 diabetes - Nephropathy markers in type 2 diabetes with sodium-glucose co-transporter 2 (SGLT2) inhibitors
Yokohama City University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2016年3月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients corresponding to any of the following are inapplicable 1) Patients with a history of allergy to any component of the study medications 2)Patients with severe complications( liver disease, mental disorder, cancer) 3)Patients with severe ketosis or diabetic coma. 4)Patients with severe infections, perioperative status, or severe trauma 5) Patients whose baseline eGFR were <29 ml/min/1.73m^2 6) Patients with kidney disease other than diabetic nephropathy.(Specifically, patients with occult blood positive) Patients with renal transplantations, or using drugs with nephrotoxic. 7)Pregnancy or lactation in women 8)Inadequacy of usingig this therapy
研究者
相似试验
已完成
不适用
Effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors on metabolic parameters in patients with type 2 diabetes: A chart-based analysistype 2 diabetesJPRN-UMIN000020314ational Center for Global Health and Medicine Kohnodai Hospital75
已完成
4 期
Effect of SGLT2 inhibitors on heart function in type 2 diabetic patients in south IndiaCTRI/2020/02/023195izams Institute of Medical Sciences
招募中
不适用
Effects of sodium-glucose co-transporter2(SGLT2) inhibitors on left ventricular systolic and/or diastolic dysfunction in Japanese type2 diabetesType2 diabetic patients with systolic and/or diastolic dysfunctionJPRN-UMIN000025841Kanagawa Cardiovascular and Respiratory Center30
终止
不适用
Effects of Sodium Glucose Co-Transpoter-2 (SGLT-2) in diabetics with heart failureCardiovascular - Other cardiovascular diseasesMetabolic and Endocrine - DiabetesType 2 DiabetesHeart failureACTRN12618000795291Endcrinology Department, Box Hill Hospital - Eastern Health2
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA